Pfizer, BioNTech covid vaccine approval tilldate
Pfizer, BioNTech covid vaccine (BNT162b2) has received following marketing authorization* approval till date.
- UK
- Bahrain
- Canada
- Mexico
- US
- Singapore
- Oman
- Saudi Arabia
- Kuwait
- EU
*Most of the approvals are emergency use authorization, not a full marketing authorization.
Quick look into approval status
UK
Temporary authorization for emergency use by MHRA on 2 December after a rolling review of vaccine data.
Bahrain
On 4 December, Bahrain became the second country to approve BNT162b2, according to a statement from the country’s National Health Regulatory Authority.
Canada
Vaccine was authorized by Health Canada on 9 December after a rolling review.
Mexico
Authorization for Emergency Use granted by COFEPRIS on 11 December.
USA
USFDA has authorized this vaccine for use in people 16 years and older under an Emergency Use Authorization on 11 December. BNT162b2 received FDA Fast Track designation in July. Pfizer plans to seek full FDA approval in April 2021.
Singapore
Interim authorization was granted to BNT162b2 by HSA for individuals 16 years and older under the under the PSAR regulatory pathway.
Chile
The Public Health Institute of Chile has authorized BNT162b2 for emergency use in the country on 16 Decembe
Oman
The country of Oman has authorized the vaccine for use in individuals 16 years and older.
Saudi Arabia
Pfizer and BioNTech’s vaccine has been authorized for use in the country by Saudi Arabia’s drug regulator.
Kuwait
The ministry of health in Kuwait has authorized BNT162b2 for emergency use.
EU
Conditionally authorized after receiving a recommendation by the EMA’s Committee for Medicinal Products for Human Use earlier in the day.
Australia
BNT162b2 received provisional determination from TGA, which is the first step on the road for approval for the vaccine in the country.
India
Pfizer has applied for an EUA for BNT162b2 with DCGI in India.
Japan
Pfizer has applied for approval of the BNT162b2 vaccine with the Ministry of Health, Labour and Welfare of Japan.
Reference:
- Covid-19 vaccine information portal by Biontech >>
- RAPS vaccine development and commercialization tracker >>
-
Pfizer and BioNTech vaccine announcement >>